Riabov, V., Xu, Q., Schmitt, N., Streuer, A., Ge, G., Bolanos, L., Wunderlich, M., Jann, J.-C., Wein, A., Altrock, E., Demmerle, M., Mukherjee, S., Ali, A. M., Rapp, F., Nowak, V., Weimer, N., Obländer, J., Palme, I., Göl, M., … Nowak, D. (2023). <i>ASXL1</i> mutations are associated with a response to alvocidib and 5-azacytidine combination in myelodysplastic neoplasms. Haematologica, 0–0. https://doi.org/10.3324/haematol.2023.282921

Prebet, T., Goldberg, A. D., Jurcic, J. G., Khaled, S., Dail, M., Feng, Y., Green, C., Li, C., Ma, C., Medeiros, B. C., Yan, M., & Grunwald, M. R. (2022). A phase 1b study of atezolizumab in combination with guadecitabine for the treatment of acute myeloid leukemia. Leukemia & Lymphoma, 63(9), 2180–2188. https://doi.org/10.1080/10428194.2022.2057484